Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|January 22, 1998
[Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time]J M Riedinger, B Coudert, I Barillot, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival modelP Foucher, B Coudert, P Arveux, et al.
Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.
Clinical Cardiology|October 2, 1998
Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiographyY Cottin, C Touzery, F Dalloz, et al.
European Journal of Nuclear Medicine|May 1, 1996
Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of womenY Cottin, C Touzery, B Coudert, et al.
Anticancer Research|January 12, 2000
MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patientsS Lizard-Nacol, P Genne, B Coudert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2012
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypesO Humbert, A Berriolo-Riedinger, J M Riedinger, et al.
Thorax|August 1, 1992
Nilutamide pneumonitis: a report on eight patientsP Pfitzenmeyer, P Foucher, F Piard, et al.
European Journal of Cancer Care|October 28, 2015
HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stableF Beltjens, A Bertaut, S Pigeonnat, et al.
Pageof 7